Rainbow Childrens Medicare Faces Neutral Evaluation Amid Declining Financial Performance

Sep 15 2025 08:13 AM IST
share
Share Via
Rainbow Childrens Medicare has experienced a recent adjustment in its evaluation score, reflecting a shift in technical trends. The company reported flat net sales of Rs 352.93 crore for the quarter ending June 2025, alongside declines in profit metrics. However, it maintains a strong debt servicing capability and high management efficiency.
Rainbow Childrens Medicare, a small-cap player in the hospital and healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical trends associated with the stock, moving from a mildly bullish stance to a more neutral position.

In terms of key financial metrics, the company reported a flat performance for the quarter ending June 2025, with net sales of Rs 352.93 crore, which represents a decline compared to previous quarters. Profit Before Tax (PBT) and Profit After Tax (PAT) also showed reductions, with PBT falling to Rs 51.35 crore and PAT to Rs 53.50 crore, indicating challenges in maintaining growth momentum.

Despite these recent figures, Rainbow Childrens Medicare has demonstrated a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 0.86 times. Additionally, the company boasts a high Return on Capital Employed (ROCE) of 21.4%, reflecting effective management efficiency.

Overall, while the stock has generated an 11.21% return over the past year, it faces pressures from declining quarterly performance metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News